| References |
1. Matsui Y, Yamaguchi T, Yamazaki T, Yoshida M, Arai M, Terasaka N, Honzumi S, Wakabayashi K, Hayashi S, Nakai D, Hanzawa H, Tamaki K. Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists. Bioorg Med Chem Lett. 2015 Sep 15;25(18):3914-20. doi: 10.1016/j.bmcl.2015.07.047. Epub 2015 Jul 23. PubMed PMID: 26238323. 2. Song K, Xu X, Liu P, Chen L, Shen X, Liu J, Hu L. Discovery and SAR study of 3-(tert-butyl)-4-hydroxyphenyl benzoate and benzamide derivatives as novel farnesoid X receptor (FXR) antagonists. Bioorg Med Chem. 2015 Oct 1;23(19):6427-36. doi: 10.1016/j.bmc.2015.08.021. Epub 2015 Aug 20. PubMed PMID: 26337021. 3. Halabi MF, Shakir RM, Bardi DA, Al-Wajeeh NS, Ablat A, Hassandarvish P, Hajrezaie M, Norazit A, Abdulla MA. Gastroprotective activity of ethyl-4-[(3,5-di-tert-butyl-2-hydroxybenzylidene) amino]benzoate against ethanol-induced gastric mucosal ulcer in rats. PLoS One. 2014 May 6;9(5):e95908. doi: 10.1371/journal.pone.0095908. eCollection 2014. PubMed PMID: 24800807; PubMed Central PMCID: PMC4011731. 4. Guo S, Wang Q, Jiang Y, Yu JT. tert-Butyl peroxybenzoate-promoted α-methylation of 1,3-dicarbonyl compounds. J Org Chem. 2014 Nov 21;79(22):11285-9. doi: 10.1021/jo502204a. Epub 2014 Oct 31. PubMed PMID: 25331571. |
